Yifei Wang
InvestorVenture Fellow (2023 Class) at LongeVC
About
Yifei Wang conducted research at McGill on Parkinson's disease and the role of vitamin D in innate immunity, and currently studies mitochondrial function in hematopoietic stem cell aging and related conditions such as leukemia, fatty liver, and atherosclerosis. She has four publications, is a member of the Longevity Biotech Fellowship program, and has worked as a consultant at Bay Area Biotech Connection and Berkeley Innovative Solution as well as a therapeutic investment fellow at UCSF Innovation Venture.
Contact· self-published, not guessed
Invests in
BiotechLongevity
Colleagues at LongeVC
Alex Zhavoronkov
Venture Partner at LongeVC
Artem Trotsyuk
Operating Partner - US at LongeVC
Artemy Shumskiy
Principal at LongeVC
Christine Yuan Huang
Advisory Board at LongeVC
Dr. Weigao Wang
Venture Fellow at LongeVC
Evelyne Bischof
Venture Partner at LongeVC
Evgeny Izumchenko
Venture Partner at LongeVC
Garri Zmudze
Managing Partner at LongeVC
Frequently asked questions
- Who is Yifei Wang?
- Yifei Wang conducted research at McGill on Parkinson's disease and the role of vitamin D in innate immunity, and currently studies mitochondrial function in hematopoietic stem cell aging and related conditions such as leukemia, fatty liver, and atherosclerosis. She has four publications, is a member of the Longevity Biotech Fellowship program, and has worked as a consultant at Bay Area Biotech Connection and Berkeley Innovative Solution as well as a therapeutic investment fellow at UCSF Innovation Venture.
- Where does Yifei Wang work?
- Yifei Wang is Venture Fellow (2023 Class) at LongeVC.
- What does Yifei Wang invest in?
- Yifei Wang invests in Biotech, Longevity.